ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy.
- Published in:
- Oncogenesis, 2018, v. 7, n. 11, p. 1, doi. 10.1038/s41389-018-0096-9
- By:
- Publication type:
- Article
Works matching IS 21579024 AND DT 2018 AND VI 7 AND IP 11
Results: 12
1
2
Muscarinic acetylcholine receptor 3 mediates vagus nerve-induced gastric cancer.
- Published in:
- Oncogenesis, 2018, v. 7, n. 11, p. 1, doi. 10.1038/s41389-018-0099-6
- By:
- Publication type:
- Article
3
Participation of xCT in melanoma cell proliferation in vitro and tumorigenesis in vivo.
- Published in:
- Oncogenesis, 2018, v. 7, n. 11, p. 1, doi. 10.1038/s41389-018-0098-7
- By:
- Publication type:
- Article
4
miR-330-5p targets SPRY2 to promote hepatocellular carcinoma progression via MAPK/ERK signaling.
- Published in:
- Oncogenesis, 2018, v. 7, n. 11, p. 1, doi. 10.1038/s41389-018-0097-8
- By:
- Publication type:
- Article
5
Aberrant ARID5B expression and its association with Ikaros dysfunction in acute lymphoblastic leukemia.
- Published in:
- Oncogenesis, 2018, v. 7, n. 11, p. 1, doi. 10.1038/s41389-018-0095-x
- By:
- Publication type:
- Article
6
The combination of cantharidin and antiangiogenic therapeutics presents additive antitumor effects against pancreatic cancer.
- Published in:
- Oncogenesis, 2018, v. 7, n. 11, p. 1, doi. 10.1038/s41389-018-0102-2
- By:
- Publication type:
- Article
7
Promotion of tumor progression and cancer stemness by MUC15 in thyroid cancer via the GPCR/ERK and integrin-FAK signaling pathways.
- Published in:
- Oncogenesis, 2018, v. 7, n. 11, p. 1, doi. 10.1038/s41389-018-0094-y
- By:
- Publication type:
- Article
8
IKKβ activates p53 to promote cancer cell adaptation to glutamine deprivation.
- Published in:
- Oncogenesis, 2018, v. 7, n. 11, p. 1, doi. 10.1038/s41389-018-0104-0
- By:
- Publication type:
- Article
9
CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancer.
- Published in:
- Oncogenesis, 2018, v. 7, n. 11, p. 1, doi. 10.1038/s41389-018-0103-1
- By:
- Publication type:
- Article
10
Upregulation of Ets1 expression by NFATc2 and NFKB1/RELA promotes breast cancer cell invasiveness.
- Published in:
- Oncogenesis, 2018, v. 7, n. 11, p. 1, doi. 10.1038/s41389-018-0101-3
- By:
- Publication type:
- Article
11
Pannexin 1 inhibits rhabdomyosarcoma progression through a mechanism independent of its canonical channel function.
- Published in:
- Oncogenesis, 2018, v. 7, n. 11, p. 1, doi. 10.1038/s41389-018-0100-4
- By:
- Publication type:
- Article
12
Development and evaluation of a novel series of Nitroxoline-derived BET inhibitors with antitumor activity in renal cell carcinoma.
- Published in:
- Oncogenesis, 2018, v. 7, n. 11, p. 1, doi. 10.1038/s41389-018-0093-z
- By:
- Publication type:
- Article